Suppr超能文献

酒精性肝病患者的肝移植:一项回顾性研究

Liver Transplantation in Patients with Alcoholic Liver Disease: A Retrospective Study.

作者信息

Vassallo Gabriele A, Tarli Claudia, Rando Maria M, Mosoni Carolina, Mirijello Antonio, Agyei-Nkansah Adwoa, Antonelli Mariangela, Sestito Luisa, Perotti Germano, Di Giuda Daniela, Agnes Salvatore, Grieco Antonio, Gasbarrini Antonio, Addolorato Giovanni

机构信息

Department of Internal Medicine, Gastroenterology and Hepatology, Catholic University of the Sacred Heart, Foundation A. Gemelli Hospital, Largo Gemelli 8, 00168 Rome, Italy.

Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza Hospital, viale Cappuccini, 71013 San Giovanni Rotondo, Italy.

出版信息

Alcohol Alcohol. 2018 Mar 1;53(2):151-156. doi: 10.1093/alcalc/agx097.

Abstract

AIM

Alcoholic liver disease (ALD) is the most common liver disease in the Western World. Liver transplantation (LT) is the treatment for end-stage ALD. However, many transplant centers are still reluctant to transplant these patients because of the risk of alcohol relapse, recurrence of the primary liver disease and associated post-transplant complications. We examined survival rate, prevalence of primary liver disease recurrence, re-transplantation and post-transplant complications among transplanted patients for alcoholic cirrhosis compared with those transplanted for viral cirrhosis.

METHODS

data about patients transplanted for alcoholic and viral cirrhosis at the Gemelli Hospital from January 1995 to April 2016 were retrospectively collected. Survival rate was evaluated according to the Kaplan-Meier method. Recurrence was defined as histological evidence of primary liver disease. Data on the onset of complication, causes of death and graft failure after liver transplant were analyzed.

RESULTS

There was no statistically significant difference regarding survival rate between the two groups. Only patients transplanted for viral cirrhosis presented with primary liver disease recurrence. There was a higher rate of cancer development in patients transplanted for alcoholic cirrhosis. Cancer was the major cause of death in this population. Risk factors associated with the onset of cancer were a high MELD score at the transplant time and smoking after transplantation.

CONCLUSION

ALD is a good indication for LT. Patients transplanted for alcoholic cirrhosis should receive regular cancer screening and should be advised against smoking.

SHORT SUMMARY

No difference was found between patients transplanted for alcoholic cirrhosis and viral cirrhosis in term of survival rate. Only patients transplanted for viral cirrhosis presented primary liver disease recurrence. A higher rate of cancer development was found in patients transplanted for alcoholic cirrohosis. This complication was associated with post-trasplant smoking.

摘要

目的

酒精性肝病(ALD)是西方世界最常见的肝脏疾病。肝移植(LT)是终末期ALD的治疗方法。然而,由于存在酒精复饮、原发性肝病复发及相关移植后并发症的风险,许多移植中心仍不愿为这些患者进行移植。我们比较了酒精性肝硬化移植患者与病毒性肝硬化移植患者的生存率、原发性肝病复发率、再次移植率及移植后并发症。

方法

回顾性收集1995年1月至2016年4月在杰梅利医院接受酒精性和病毒性肝硬化移植患者的数据。根据Kaplan-Meier法评估生存率。复发定义为原发性肝病的组织学证据。分析肝移植后并发症的发生情况、死亡原因及移植物功能衰竭的数据。

结果

两组患者的生存率无统计学显著差异。仅病毒性肝硬化移植患者出现原发性肝病复发。酒精性肝硬化移植患者的癌症发生率较高。癌症是该人群的主要死亡原因。与癌症发生相关的危险因素是移植时较高的终末期肝病模型(MELD)评分及移植后吸烟。

结论

ALD是LT的良好适应证。酒精性肝硬化移植患者应接受定期癌症筛查,并应被告知戒烟。

简短总结

酒精性肝硬化移植患者和病毒性肝硬化移植患者在生存率方面无差异。仅病毒性肝硬化移植患者出现原发性肝病复发。酒精性肝硬化移植患者的癌症发生率较高。这种并发症与移植后吸烟有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验